Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancers

Key Points

• Fermt1 expression correlates with patient survival and tumor progression across multiple cancers, indicating its importance.
• Key evidence shows that elevated Fermt1 levels are associated with improved immunotherapy response in lung adenocarcinoma.
• The approach includes a multi-omics analysis, revealing insights into cancer biology and treatment implications across various cancer types.
• This highlights the potential of Fermt1 as a therapeutic target, but further validation across diverse patient populations is needed.